|
|
News for Healthier Living
Blood Marker Shows Promise for Tracking Oxaliplatin-Related Nerve Damage
A research team has found preliminary evidence that a blood-based marker of nerve injury could help researchers track peripheral neurotoxicity caused by oxaliplatin, a chemotherapy drug used to treat colorectal cancer. In a study of 28 patients, serum neurofilament light chain (sNfL) increased during treatment and remained elevated three months afterward, alongside worsening neuropathy assessments. Higher follow-up concentrations were associated with more severe clinical signs and patient-reported symptoms. The findings suggest that sNfL could complement existing assessments in trials evaluating interventions to prevent chemotherapy-related nerve damage, providing an objective measure of changes in nerve injury.
November 9, 2026
November 9 2026November 8 2026November 7 2026November 6 2026November 5 2026November 4 2026November 3 2026November 2 2026November 1 2026October 30 2026October 29 2026October 28 2026October 27 2026October 26 2026
|
|
|
|
|